(Q32032862)

5 July 2017

title

Regular versus as-needed short-acting inhaled beta-agonist therapy for chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

5 July 2017

main subject

1 reference

2

Guyatt G

1 reference

5 July 2017

Cook D

1

1 reference

5 July 2017

Wong E

3

1 reference

5 July 2017

Goldstein R

4

1 reference

5 July 2017

Bedard M

5

1 reference

5 July 2017

Austin P

6

1 reference

5 July 2017

Ramsdale H

7

1 reference

5 July 2017

Jaeschke R

8

1 reference

5 July 2017

Sears M

9

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

American Journal of Respiratory and Critical Care Medicine

5 July 2017

published in

1 reference

5 July 2017

volume

163

1 reference

5 July 2017

issue

1

1 reference

5 July 2017

page(s)

85-90

1 reference

Dose-response study of inhaled salbutamol powder in chronic airflow obstruction

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2004214

High dose salbutamol in chronic bronchitis: comparison of 400 micrograms, 1 mg, 1.6 mg, 2 mg and placebo delivered by Rotahaler

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2004214

Effect of increasing doses of beta agonists on spirometric parameters, exercise capacity, and quality of life in patients with chronic airflow limitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2004214

Regular inhaled beta-agonist treatment in bronchial asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2004214

Regular inhaled salbutamol and asthma control: the TRUST randomised trial. Therapy Working Group of the National Asthma Task Force and the MRC General Practice Research Framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2004214

Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2004214

Effect of encouragement on walking test performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2004214

Measurement of health status. Ascertaining the minimal clinically important difference

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2004214

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2004214

Interpretation of rhinoconjunctivitis quality of life questionnaire data

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2004214

Pulmonary rehabilitation of early COPD. COPD as a systemic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2004214

10.1164/AJRCCM.163.1.2004214

21 January 2018

Identifiers

DOI

1 reference

5 July 2017

1 reference